Mark Lundie

Direttore/Membro del Consiglio presso Clinical Trials Ontario

Commercial Services

Health Technology

Finance

Profilo

Mark Lundie is currently serving as a Board of Director at Ontario Genomics Institute (Private Equity) and as a Director at Clinical Trials Ontario.
He previously worked as the Chairman at Centre For Probe Development & Commercialization.

Posizioni attive di Mark Lundie

Società	Posizione	Inizio
Clinical Trials Ontario Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada.	Direttore/Membro del Consiglio	-
Ontario Genomics Institute (Private Equity) Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Mark Lundie

Precedenti posizioni note di Mark Lundie

Società	Posizione	Fine
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Presidente	-

Vedi nel dettaglio l'esperienza di Mark Lundie

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mark Lundie

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
Clinical Trials Ontario Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada.	Commercial Services
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Health Technology
Ontario Genomics Institute (Private Equity) Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.	Finance

Vedi le connessioni aziendali